Quick Links

Author: Tina Taylor

Thank you for your interest in participating in the Automation and Adults study. The main purpose of the study is to examine your perspective on automation and your daily experiences. To be eligible for the study, you must meet ALL of the following criteria:  You are...

The Cobra study is testing whether vedolizumab is safe and potentially effective in adults with type 1 diabetes (T1D) on its own or when following pre-treatment with etanercept. We are testing the combination of vedolizumab and etanercept combination because we think these two drugs may have...

For people age 12 – 35 years who have been diagnosed with type 1 diabetes in the past 3 months, this study tests two JAK inhibitors (abrocitinib and ritlecitinib) to see if either or both can preserve insulin production. TrialNet researchers are testing two different JAK...

For adults age 18 – 45 years who have been diagnosed with type 1 diabetes in the past 18 months, the DESIGNATE study will test whether a new drug called siplizumab will reduce or block the T-cells that attack the insulin-producing beta cells. The goal of...

SITE PARTNERS
uw-footer